Blair William & Co. IL Boosts Stake in Chemed Co. (NYSE:CHE)

Blair William & Co. IL boosted its position in Chemed Co. (NYSE:CHE) by 3.2% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 2,476 shares of the company’s stock after purchasing an additional 76 shares during the quarter. Blair William & Co. IL’s holdings in Chemed were worth $1,343,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also modified their holdings of the company. Waterloo Capital L.P. increased its stake in Chemed by 2.8% in the second quarter. Waterloo Capital L.P. now owns 2,364 shares of the company’s stock valued at $1,283,000 after purchasing an additional 64 shares during the last quarter. Mercer Global Advisors Inc. ADV grew its stake in Chemed by 4.7% during the second quarter. Mercer Global Advisors Inc. ADV now owns 1,545 shares of the company’s stock worth $838,000 after buying an additional 70 shares during the period. Bradley Foster & Sargent Inc. CT purchased a new stake in Chemed during the 2nd quarter worth $250,000. Edgestream Partners L.P. raised its position in Chemed by 748.8% in the second quarter. Edgestream Partners L.P. now owns 13,640 shares of the company’s stock valued at $7,401,000 after purchasing an additional 12,033 shares during the period. Finally, Quantbot Technologies LP raised its holdings in shares of Chemed by 135.3% during the 2nd quarter. Quantbot Technologies LP now owns 7,057 shares of the company’s stock valued at $3,829,000 after buying an additional 4,058 shares during the period. Institutional investors and hedge funds own 95.85% of the company’s stock.

Insider Activity at Chemed

In other Chemed news, EVP Nicholas Michael Westfall sold 2,000 shares of the firm’s stock in a transaction on Tuesday, July 30th. The shares were sold at an average price of $561.58, for a total transaction of $1,123,160.00. Following the completion of the transaction, the executive vice president now directly owns 5,990 shares of the company’s stock, valued at approximately $3,363,864.20. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. In other Chemed news, EVP Nicholas Michael Westfall sold 2,000 shares of the stock in a transaction that occurred on Tuesday, July 30th. The stock was sold at an average price of $561.58, for a total transaction of $1,123,160.00. Following the transaction, the executive vice president now owns 5,990 shares of the company’s stock, valued at approximately $3,363,864.20. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, Director Andrea R. Lindell sold 831 shares of the business’s stock in a transaction that occurred on Friday, August 16th. The shares were sold at an average price of $571.51, for a total value of $474,924.81. Following the completion of the sale, the director now owns 5,725 shares of the company’s stock, valued at $3,271,894.75. The disclosure for this sale can be found here. Insiders have sold 6,744 shares of company stock valued at $3,828,231 over the last ninety days. Corporate insiders own 3.32% of the company’s stock.

Chemed Trading Up 1.2 %

NYSE CHE opened at $589.28 on Tuesday. Chemed Co. has a 52 week low of $497.36 and a 52 week high of $654.62. The stock has a market cap of $8.92 billion, a P/E ratio of 31.72, a PEG ratio of 2.31 and a beta of 0.44. The company’s fifty day simple moving average is $570.39 and its 200-day simple moving average is $576.80.

Chemed (NYSE:CHE) last released its quarterly earnings results on Wednesday, July 24th. The company reported $5.47 EPS for the quarter, missing the consensus estimate of $5.59 by ($0.12). Chemed had a return on equity of 29.21% and a net margin of 12.88%. The business had revenue of $595.88 million during the quarter, compared to analyst estimates of $599.20 million. During the same quarter last year, the firm posted $4.71 EPS. The company’s revenue was up 7.6% compared to the same quarter last year. On average, research analysts expect that Chemed Co. will post 21.77 EPS for the current fiscal year.

Chemed Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, August 30th. Investors of record on Monday, August 12th were paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.34%. The ex-dividend date of this dividend was Monday, August 12th. This is a positive change from Chemed’s previous quarterly dividend of $0.40. Chemed’s payout ratio is 10.76%.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.